: Sildenafil citrate is an approved drug used for the treatment of erectile dysfunction and premature ejaculation. Despite a widespread application, sildenafil citrate shows numerous adverse cardiovascular effects in high-risk patients. Local transdermal drug delivery of this drug is therefore being explored as an interesting and noninvasive alternative administration method that avoids adverse effects arised from peak plasma drug concentrations. Although human and animal skin represents the most reliable models to perform penetration studies, they involve a series of ethical issues and restrictions. For these reasons new in vitro approaches based on artificially reconstructed human skin or "human skin equivalents" are being developed as possible alternatives for transdermal testing. There is little information, however, on the efficiency of such new in vitro methods on cutaneous penetration of active ingredients. The objective of the current study was to investigate the sildenafil citrate loaded in three commercial transdermal vehicles using 3D full-thickness skin equivalent and compare the results with the permeability experiments using porcine skin. Our results demonstrated that, while the formulation plays an imperative role in an appropriate dermal uptake of sildenafil citrate, the D coefficient results obtained by using the 3D skin equivalent are comparable to those obtained by using the porcine skin when a simple drug suspension is applied (1.17 × 10-10 ± 0.92 × 10-10 cm2/s vs 3.5 × 102 ± 3.3 × 102 cm2/s), suggesting that in such case, this 3D skin model can be a valid alternative for ex-vivo skin absorption experiments.

3D human foreskin model for testing topical formulations of sildenafil citrate / Magnano, Greta Camilla; Quadri, Marika; Palazzo, Elisabetta; Lotti, Roberta; Loschi, Francesca; Dall'Acqua, Stefano; Abrami, Michela; Larese Filon, Francesca; Marconi, Alessandra; Hasa, Dritan. - In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. - ISSN 0378-5173. - 649:(2024), pp. 123612-123623. [10.1016/j.ijpharm.2023.123612]

3D human foreskin model for testing topical formulations of sildenafil citrate

Quadri, Marika;Palazzo, Elisabetta;Lotti, Roberta;Marconi, Alessandra
;
2024

Abstract

: Sildenafil citrate is an approved drug used for the treatment of erectile dysfunction and premature ejaculation. Despite a widespread application, sildenafil citrate shows numerous adverse cardiovascular effects in high-risk patients. Local transdermal drug delivery of this drug is therefore being explored as an interesting and noninvasive alternative administration method that avoids adverse effects arised from peak plasma drug concentrations. Although human and animal skin represents the most reliable models to perform penetration studies, they involve a series of ethical issues and restrictions. For these reasons new in vitro approaches based on artificially reconstructed human skin or "human skin equivalents" are being developed as possible alternatives for transdermal testing. There is little information, however, on the efficiency of such new in vitro methods on cutaneous penetration of active ingredients. The objective of the current study was to investigate the sildenafil citrate loaded in three commercial transdermal vehicles using 3D full-thickness skin equivalent and compare the results with the permeability experiments using porcine skin. Our results demonstrated that, while the formulation plays an imperative role in an appropriate dermal uptake of sildenafil citrate, the D coefficient results obtained by using the 3D skin equivalent are comparable to those obtained by using the porcine skin when a simple drug suspension is applied (1.17 × 10-10 ± 0.92 × 10-10 cm2/s vs 3.5 × 102 ± 3.3 × 102 cm2/s), suggesting that in such case, this 3D skin model can be a valid alternative for ex-vivo skin absorption experiments.
2024
21-nov-2023
649
123612
123623
3D human foreskin model for testing topical formulations of sildenafil citrate / Magnano, Greta Camilla; Quadri, Marika; Palazzo, Elisabetta; Lotti, Roberta; Loschi, Francesca; Dall'Acqua, Stefano; Abrami, Michela; Larese Filon, Francesca; Marconi, Alessandra; Hasa, Dritan. - In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. - ISSN 0378-5173. - 649:(2024), pp. 123612-123623. [10.1016/j.ijpharm.2023.123612]
Magnano, Greta Camilla; Quadri, Marika; Palazzo, Elisabetta; Lotti, Roberta; Loschi, Francesca; Dall'Acqua, Stefano; Abrami, Michela; Larese Filon, Fr...espandi
File in questo prodotto:
File Dimensione Formato  
Pre-print Manuscript_3D Skin Model_Magnano et al.pdf

embargo fino al 15/01/2025

Descrizione: Pre-print manuscript
Tipologia: Versione originale dell'autore proposta per la pubblicazione
Dimensione 765.89 kB
Formato Adobe PDF
765.89 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
1-s2.0-S0378517323010335-main.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 5.82 MB
Formato Adobe PDF
5.82 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1329530
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact